Gene Therapy Maker Sarepta Tells FDA It Won’t Halt Shipments Despite Patient Deaths
Sarepta Therapeutics faces scrutiny after refusing to pause shipments of its gene therapy treatment following multiple patient deaths. Here’s what the FDA, experts, and the public are saying. A Storm in the Biotech World: Sarepta Draws Line in the Sand In a bold and controversial move, gene therapy pioneer Sarepta Therapeutics has told the U.S. … Read more